Description
Model program used in paper in Lancet Global Health entitled Potential cost-effectiveness of community availability of tenofovir-lamivudine-dolutegravir for HIV prevention and treatment in East, Central, Southern and West Africa: a modelling analysis
Includes the model program itself and the program to analyse model outputs.
Includes the model program itself and the program to analyse model outputs.
| Date made available | 1 Sept 2023 |
|---|---|
| Publisher | tbc |
Research output
- 1 Article
-
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis
Phillips, A. N., Bansi-Matharu, L., Shahmanesh, M., Hargreaves, J. R., Smith, J., Revill, P., Sibanda, E., Ehrenkranz, P., Sikwese, K., Rodger, A., Lundgren, J. D., Gilks, C. F., Godfrey, C., Cowan, F. & Cambiano, V., 1 Oct 2023, In: The Lancet Global Health. 11, 10, p. e1648-e1657Research output: Contribution to journal › Article › peer-review
Open AccessFile11 Citations (Scopus)
Cite this
- DataSetCite